Gallium citrate ga-67
Gallium citrate ga-67: 4 brands, 0 generics.
No listed patents or exclusivity: brand product(s) only.
Brand (NDA) products
- GALLIUM CITRATE GA 67CURIUMNDA 018058-
Approved strengths under this FDA application. Strength Dosage form Route Status TE 2mCi/ML INJECTABLE INJECTION Rx BS - GALLIUM CITRATE GA 67GE HEALTHCARENDA 017700-
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1mCi/ML INJECTABLE INJECTION Discontinued - - GALLIUM CITRATE GA 67LANTHEUS MEDCLNDA 017478-
Approved strengths under this FDA application. Strength Dosage form Route Status TE 2mCi/ML INJECTABLE INJECTION Discontinued - - GE HEALTHCARENDA 017655-
Approved strengths under this FDA application. Strength Dosage form Route Status TE 2mCi/ML INJECTABLE INJECTION Discontinued -
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Gallium citrate ga-67: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Assyro Intelligence
Ask anything about Gallium citrate ga-67
Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.
Evaluating for a team? Book a demo